ORIGINAL RESEARCH
Accepted on 29 Sep 2025
Real-World Safety of Ixekizumab: A Disproportionality Analysis Using the FDA Adverse Event Reporting System and the VigiAccess databases
doi 10.3389/fmed.2025.1652401
- Frontiers in Medicine
- Dermatology
- Research Topics
- Exploring Cutaneous Drug-Related and Drug-Associated Adverse Events: From Clinical Insight to Therapeutic Management
Exploring Cutaneous Drug-Related and Drug-Associated Adverse Events: From Clinical Insight to Therapeutic Management
103
Total downloads
1,419
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
CASE REPORT
Published on 29 Sep 2025
Iatrogenic Cushing’s syndrome induced by topical steroid abuse in a patient with psoriasis: a case report
doi 10.3389/fmed.2025.1591869
- 368 views
CASE REPORT
Accepted on 10 Sep 2025
Psoriasis caused by camrelizumab in a patient with esophageal cancer: a case report
doi 10.3389/fmed.2025.1647297
- 159 views
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.